PS
ABBV icon

Planning Strategies’s AbbVie ABBV Stock Holding History

Planning Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
+1,001
New +$215K 0.16% 58

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Planning Strategies's ABBV Position: Q2 2026 in Review

Planning Strategies opened a new position in AbbVie (ABBV) in Q2 2026: 1,001 shares worth $252K. The stake represents 0.16% of the portfolio and ranks #58 among its holdings.

4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Planning Strategies held 1,001 shares of AbbVie worth $252K as of Q2 2026.
  • AbbVie was a new Planning Strategies position in Q2 2026.
  • AbbVie made up 0.16% of Planning Strategies's portfolio in Q2 2026, its #58 holding.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Planning Strategies's 13F filing for Q2 2026, filed 27 Jul 2026.